AmplifyBio scoops up lab space and other assets from PACT Pharma as cell therapy biotech readjusts
The West Coast cell therapy biotech PACT Pharma was facing some challenges after several employees got the axe from the company and execs put the kibosh on its only clinical trial. Now, the company has sold some of its assets to an Ohio-based contract research organization.
AmplifyBio has acquired a 46,280 square-foot lab in South San Francisco, CA, with around 40 employees specializing in cell and gene therapy development and access to technology platforms that can be applied to “product characterization.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.